Back to funds

Pivotal bioVenture Partners Investment Advisor LLC

hedge fundUpdated 9 days ago

Managed by Pivotal Bioventure Partners Investment Advisor Llc • Latest filing Q3 2026

Portfolio value
$251.8M
Q3 2026
Filings
4
Quarterly 13F history
Top-10 concentration
100.0%
Weight of largest holdings
Annualized return
—
Implied from 13F holdings

Portfolio value history

13F-disclosed portfolio value over 4 quarters

Show data table
PeriodPortfolio value
Q4 2025$258.7M
Q1 2026$279.8M
Q2 2026$307.8M
Q3 2026$251.8M

Top holdings

14 positions as of Q3 2026

View filing
P

VAXCYTE INC

Value
$81.1M
Shares
1.43M
% Port
32.22%
A

ARCUTIS BIOTHERAPEUTICS INC

Value
$26.6M
Shares
1.01M
% Port
10.58%
T

TREVI THERAPEUTICS INC

Value
$25M
Shares
1.74M
% Port
9.91%
A

AVALYN PHARMACEUTICALS INC

Value
$24.7M
Shares
866.8K
% Port
9.81%
E

EVOMMUNE INC

Value
$15.9M
Shares
1.93M
% Port
6.32%
I

IMMUNOME INC

Value
$15.8M
Shares
732.5K
% Port
6.26%
O

OCULIS HOLDING AG

Value
$15.5M
Shares
1.66M
% Port
6.15%
O

OBSIDIAN THERAPEUTICS INC

Value
$11.8M
Shares
860.3K
% Port
4.69%
A

AVALO THERAPEUTICS INC

Value
$6.7M
Shares
434.0K
% Port
2.64%
?
10.N/A

BRAVEHEART BIO INC

Value
$6.4M
Shares
317.4K
% Port
2.55%
Z

ZENAS BIOPHARMA INC

Value
$6.3M
Shares
233.2K
% Port
2.50%
M

MAPLIGHT THERAPEUTICS INC

Value
$6.2M
Shares
611.4K
% Port
2.47%
R

RALLYBIO CORP

Value
$5.2M
Shares
300.6K
% Port
2.05%
B

BIOAGE LABS INC

Value
$4.6M
Shares
653.4K
% Port
1.84%

Explore